pirtobrutinib
eli lilly
['pirto', 'thanks']
thanks to of for coming by to discuss her #asco23 presentation on the long-term safety with at least 12 months of pirtobrutinib in r/r b-cell malignancies! be sure to check out her poster discussion session tomorrow and stay tuned for the video! 
Translating Hematologic Oncology Discoveries into Practice.